PDS Biotechnology Corp (NAS:PDSB)
$ 1.64 -0.03 (-1.8%) Market Cap: 61.35 Mil Enterprise Value: 36.27 Mil PE Ratio: 0 PB Ratio: 2.74 GF Score: 31/100

PDS Biotechnology Corp To Host Post ASCO Call Transcript

Jun 06, 2023 / 12:00PM GMT
Release Date Price: $6.24 (-4.44%)
Operator

Good morning, and welcome to PDS Biotechnology's post 2023 ASCO Conference Call and Webcast. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Matt Hill, Chief Financial Officer.

Before we begin, we want to remind everyone that on today's call, the company will be making forward-looking statements regarding regulatory and product candidate development plans, as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in PDS Biotech's most recent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. Except to the extent required by applicable law or regulation, PDSB undertakes no obligation to update the forward-looking statements included today to reflect subsequent events or circumstances.

With that, I would now like to turn the call over to Dr. Frank Bedu-Addo. Frank?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot